These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11430166)

  • 1. Collateral damage. Providers face negative fallout from the war on drugmakers.
    Taylor M
    Mod Healthc; 2001 Jun; 31(24):30-3. PubMed ID: 11430166
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent multistate enforcement initiatives: prescription drug promotional practices.
    Woodward D
    Food Drug Law J; 1995; 50(2):295-300. PubMed ID: 10342997
    [No Abstract]   [Full Text] [Related]  

  • 3. Bill 102: deal or no deal for big pharma.
    Rasky H
    Health Law Can; 2007 May; 27(4):73-84. PubMed ID: 17580795
    [No Abstract]   [Full Text] [Related]  

  • 4. Providers offer prescription for Medicaid drug-pricing law.
    Chaconas J
    Trustee; 1991 Dec; 44(12):12, 19. PubMed ID: 10115321
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent case developments in health law. Pharmaceutical price-fixing and consumer protection: Blue Cross & Blue Shield v. AstraZeneca Pharmaceuticals LP.
    Clark S
    J Law Med Ethics; 2010; 38(1):160-2. PubMed ID: 20446995
    [No Abstract]   [Full Text] [Related]  

  • 6. Are hospitals next in line? Government investigators probing relationships between physicians, devicemakers may soon train sights on hospitals.
    Taylor M
    Mod Healthc; 2006 Aug; 36(32):24-6. PubMed ID: 16958280
    [No Abstract]   [Full Text] [Related]  

  • 7. Four found whistleblowing the best revenge.
    Taylor M
    Mod Healthc; 2001 Jun; 31(24):32-3. PubMed ID: 11430167
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugmakers fight for good name. Stakes high, challenges many for providers who seek generic products.
    Becker C
    Mod Healthc; 2001 Aug; 31(35):28-33, 1. PubMed ID: 11550428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tapped for $800 million. Drugmakers' joint venture will pay what could be biggest fraud settlement.
    Taylor M
    Mod Healthc; 2001 Apr; 31(17):8-9. PubMed ID: 11338904
    [No Abstract]   [Full Text] [Related]  

  • 10. State consumer fraud legislation applied to the health care industry. Are health care professionals being "consumed"?
    Bundren LA
    J Leg Med; 1995 Mar; 16(1):133-66. PubMed ID: 7738440
    [No Abstract]   [Full Text] [Related]  

  • 11. Industry probe. Justice Department subpoenas dialysis providers.
    Mantone J
    Mod Healthc; 2004 Nov; 34(44):17. PubMed ID: 15554339
    [No Abstract]   [Full Text] [Related]  

  • 12. Generics still a favorite Rx for savings.
    Wagner M
    Mod Healthc; 1990 May; 20(21):26-8, 30, 32-3. PubMed ID: 10104890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When is a rebate a kickback?
    Barnes JE
    US News World Rep; 2002 Aug; 133(6):31-3. PubMed ID: 12195768
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugmakers' price plan ruled to be price-fixing by agency.
    Burda D
    Mod Healthc; 1993 Oct; 23(41):8. PubMed ID: 10129330
    [No Abstract]   [Full Text] [Related]  

  • 15. Cephalosporin prices climb at slower rate in 1992.
    Barlow RD
    Hosp Mater Manage; 1992 Jul; 17(7):1, 12-3. PubMed ID: 10119968
    [No Abstract]   [Full Text] [Related]  

  • 16. 22 states file suit against Sandoz.
    Wagner M
    Mod Healthc; 1990 Dec 24-31; 20(51):10. PubMed ID: 10108104
    [No Abstract]   [Full Text] [Related]  

  • 17. Roundtable discussion. Cost justification of innovative drugs through assessment of total health care costs.
    Rybak MJ; Allen R; Craven PC; Freeman R; Nightingale CH; Normand C; Rubinstein E; Schaison GS; Whitelaw G
    Hosp Formul; 1993 Jan; 28 Suppl 1():33-6. PubMed ID: 10123836
    [No Abstract]   [Full Text] [Related]  

  • 18. Defending an emerging threat: consumer fraud class action suits in pharmaceutical and medical device products-based litigation.
    Leghorn JJ; Allen C; Brewington T
    Food Drug Law J; 2006; 61(3):519-38. PubMed ID: 16989037
    [No Abstract]   [Full Text] [Related]  

  • 19. Intellectual property. NIH weighs demand to force sharing of AIDS drug patents.
    Malakoff D
    Science; 2004 Jun; 304(5676):1427-9. PubMed ID: 15178775
    [No Abstract]   [Full Text] [Related]  

  • 20. Why do drug companies fear this man?
    Simons J
    Fortune; 2003 Oct; 148(9):167-8, 170, 172. PubMed ID: 14584310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.